106
Participants
Start Date
November 4, 2019
Primary Completion Date
May 14, 2021
Study Completion Date
November 30, 2021
aflibercept
Intravitreally (IVT) administered as a liquid formulation in a vial
High-dose aflibercept
Intravitreally (IVT) administered as a liquid formulation in a vial
Regeneron Study Site, Great Neck
Regeneron Study Site, Kingston
Regeneron Study Site, Hagerstown
Regeneron Study Site, Fairfax
Regeneron Study Site, Morgantown
Regeneron Study Site, Charlotte
Regeneron Study Site, Asheville
Regeneron Study Site, West Columbia
Regeneron Study Site, Ladson
Regeneron Study Site, Marietta
Regeneron Study Site, Augusta
Regeneron Study Site, Tallahassee
Regeneron Study Site, Melbourne
Regeneron Study Site, Fort Lauderdale
Regeneron Study Site, Largo
Regeneron Study Site, Lakeland
Regeneron Study Site, Winter Haven
Regeneron Study Site, Fort Myers
Regeneron Study Site, Columbus
Regeneron Study Site, Royal Oak
Regeneron Study Site, Rapid City
Regeneron Study Site, Oak Forest
Regeneron Study Site, Edmond
Regeneron Study Site, Arlington
Regeneron Study Site, Houston
Regeneron Study Site, The Woodlands
Regeneron Study Site, Austin
Regeneron Study Site, Abilene
Regeneron Study Site, Golden
Regeneron Study Site, Colorado Springs
Regeneron Study Site, Salt Lake City
Regeneron Study Site, Phoenix
Regeneron Study Site, Sun City
Regeneron Study Site, Albuquerque
Regeneron Study Site, Encino
Regeneron Study Site, Palm Desert
Regeneron Study Site, Santa Ana
Regeneron Study Site, Fullerton
Regeneron Study Site, Mountain View
Regeneron Study Site, Sacramento
Regeneron Study Site, Portland
Regeneron Study Site, Spokane
Regeneron Study Site, Waterford
Regeneron Study Site, Bloomfield
Regeneron Study Site, Teaneck
Regeneron Study Site, Arecibo
Collaborators (1)
Bayer
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY